on Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present at Barclays Science Call Series
Cambridge-based Moderna, Inc. will participate in the upcoming Barclays Speaking the Science Call Series. The event is scheduled for June 16, 2025, at 10:00am ET. Investors may access a live webcast of the presentation via the Moderna website under the "Events and Presentations" section.
The webcast will be archived on Moderna's website for at least 30 days post-presentation, allowing interested parties flexibility in viewing. This event provides Moderna an opportunity to engage with investors and discuss developments in mRNA technology and their applications.
Moderna, known for its mRNA platform, continues to advance its therapeutic solutions across various medical fields, including infectious diseases and immuno-oncology.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Moderna, Inc. news